Skip to content

Trial Summary

What are the specific risk factors related to poor outcome in cancer patients infected with COVID-19 virus?

Acronym:

COVID19

ACTRN/NCT /ethics:

Scientific title:

Sponsor / Cooperative group:

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial Type-
Phase-
Age Range-
Sex-
Tumour Stream Cancer-related Subgroup
Cancer Stage-
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorHannah Adelson
EmailHannah.adelson@sa.gov.au
Phone08 8206 4835
Principal InvestigatorDr Amitesh Roy
Recruitment StatusRecruiting